Results 101 to 110 of about 39,894 (208)

In Vitro Physicochemical and Pharmacokinetic Properties of Bevacizumab Dissolved in Silicone Oils Compared to Hydrogel-Substitutes and Porcine Vitreous Bodies

Gels
Anti-VEGF agents, e.g., bevacizumab, are used in retinal surgery, while their interaction with silicone oils and novel hydrogels remains unclear. This study examines the in vitro pharmacokinetics of bevacizumab in silicone oil-filled eyes compared to ...
Maximilian Hammer, Jonathan Herth, Lorenz Herbster, Manuel Ben Böhmann, Marcel Muuss, Ramin Khoramnia, Alexander Scheuerle, Walter Mier, Sabrina Wohlfart, Gerd Uwe Auffarth, Philipp Uhl   +10 more
doaj   +1 more source

Studies on the vitreous body. II [PDF]

Biochemical Journal, 1935
W S, Duke-Elder, H, Davson
openaire   +2 more sources

Retinal Aquaporin-4 and Regulation of Water Inflow Into the Vitreous Body. [PDF]

Invest Ophthalmol Vis Sci, 2021
Ueki S, Suzuki Y, Igarashi H.
europepmc   +1 more source

Prognostic Factors for Postoperative Complications. An Aggregate Protocol for 10 Observational Studies From the Danish TRIPLE‐A Cohort of 1.2 Million Surgeries

Acta Anaesthesiologica Scandinavica, Volume 70, Issue 7, August 2026.
ABSTRACT Background Postoperative complications substantially increase morbidity, mortality and healthcare costs. Understanding prognostic factors is essential for risk stratification, targeted prevention strategies, and development of prediction models.
Anders Peder Højer Karlsen, Asta Prescott, Caroline Folkersen, Jens Laigaard, Atena Saito, Caroline Lando Klammer, Mik Wetterslev, Emil Ipsen Ørskov, Mathilde Fahrendorff, Rebecca Kiær, Helene Holm Laigaard, Nichlas Hovmand, Lars Hyldborg Lundstrøm, Sebastian Buhl Rasmussen, Anders Kehlet Nørskov, Markus Harboe Olsen   +15 more
wiley   +1 more source

Visual Blurring Following Posterior Vitreous Detachment in Fuchs Uveitis Syndrome

Journal of Ophthalmic & Vision Research
Purpose: To describe the clinical presentation, diagnostic challenges, management, and visual outcome of acute posterior vitreous detachment (PVD) in patients with Fuchs uveitis syndrome (FUS) Methods: This retrospective case series included ...
Alireza Hedayatfar, Soon-Phaik Chee
doaj   +1 more source

Reattachment After Foldable Capsular Vitreous Body Implantation in Severe Retinal Detachment Eyes. [PDF]

Transl Vis Sci Technol, 2021
Chen S, Tian M, Zhang L, Hu C, Liu K, Qin B, Liu S.   +6 more
europepmc   +1 more source

Randomized, single‐centre, double‐blinded repeated dose investigation of safety and tolerability of ocular administrations of a novel silica eye drop product in healthy volunteers

Acta Ophthalmologica, Volume 104, Issue 5, Page 572-579, August 2026.
Abstract Purpose Managing ocular diseases often requires frequent eye drop administration, which can challenge patient compliance. A long‐acting eye drop technology using an amorphous synthetic silica composite was developed to address this. Our study aimed to assess the safety and tolerability of the Silica Eye Drop platform in healthy volunteers over
Aleksandra Poluianova, Marceline N. Akieh‐Pirkanniemi, Arto Hartikainen, Hanna Arstila, Kai Kaarniranta, Lasse Leino   +5 more
wiley   +1 more source

Long-Term Biocompatibility of a Highly Viscously Thiol-Modified Cross-Linked Hyaluronate as a Novel Vitreous Body Substitute. [PDF]

Front Pharmacol, 2022
Hurst J, Rickmann A, Heider N, Hohenadl C, Reither C, Schatz A, Schnichels S, Januschowski K, Spitzer MS.   +8 more
europepmc   +1 more source

Axial length as a risk factor for pseudophakic rhegmatogenous retinal detachment: A Danish registry study

Acta Ophthalmologica, Volume 104, Issue 5, Page 517-525, August 2026.
Abstract Purpose To examine axial length as a risk factor for pseudophakic rhegmatogenous retinal detachment (pRRD). Methods We identified eyes that underwent phacoemulsification between 2 May 2002 and 10 November 2023 and had an axial length registered at the Departments of Ophthalmology in the Capital Region of Denmark or the private clinic ...
Ditte‐Marie Leegaard Holm, Birgitte Romme Nielsen, Mark Bech Knudsen, Torben Martinussen, Jakob Grauslund, Morten la Cour, Mark Alberti, Therese Grønhøj Krarup   +7 more
wiley   +1 more source

Trends in Second‐Line Initiations and Treatment Outcomes Across Age and Frailty Groups in People With Type 2 Diabetes: UK Population‐Based Study, 2019–2024

Diabetes, Obesity and Metabolism, Volume 28, Issue 8, Page 7471-7482, August 2026.
ABSTRACT Aims To assess contemporary UK trends in second‐line treatment initiations and outcomes across age‐and‐frailty groups in people with type 2 diabetes (T2D). Materials and Methods We studied 117 046 UK adults with T2D initiating second‐line therapy between 2019–2024 (Clinical Practice Research Datalink).
M. M. Dinsdale, K. G. Young, P. Cardoso, L. M. Güdemann, T. T. Jansz, A. P. McGovern, A. G. Jones, E. R. Pearson, A. T. Hattersley, T. J. McKinley, B. M. Shields, J. M. Dennis   +11 more
wiley   +1 more source